Donald L. III Reeves, the SVP of $ITRI, sold 303 shares of the company on 12-10-2025 for an estimated $29,281. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.6% of their shares of this class of stock. Following this trade, they now own 18,542 shares of this class of $ITRI stock.
$ITRI Insider Trading Activity
$ITRI insiders have traded $ITRI stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $ITRI stock by insiders over the last 6 months:
- THOMAS DEITRICH (President & CEO) has made 0 purchases and 2 sales selling 3,536 shares for an estimated $392,684.
- JOAN S HOOPER (SVP & CFO) has made 0 purchases and 2 sales selling 1,918 shares for an estimated $213,035.
- DONALD L. III REEVES (SVP, Outcomes) has made 0 purchases and 4 sales selling 1,609 shares for an estimated $171,102.
- JOHN F. MARCOLINI (SVP, Networked Solutions) has made 0 purchases and 2 sales selling 1,118 shares for an estimated $124,166.
- JUSTIN K PATRICK (SVP, Device Solutions) has made 0 purchases and 2 sales selling 767 shares for an estimated $85,194.
- CHRISTOPHER E. WARE (SVP, GC & Corp. Secretary) has made 0 purchases and 2 sales selling 694 shares for an estimated $77,084.
- LAURIE ANN PULATIE-HAHN (SVP, HR) has made 0 purchases and 3 sales selling 296 shares for an estimated $33,928.
- DAVID MARSHALL WRIGHT (VP, Corp. Controller & CAO) has made 0 purchases and 2 sales selling 210 shares for an estimated $23,319.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ITRI Hedge Fund Activity
We have seen 223 institutional investors add shares of $ITRI stock to their portfolio, and 260 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- IMPAX ASSET MANAGEMENT GROUP PLC added 890,040 shares (+127.3%) to their portfolio in Q3 2025, for an estimated $110,863,382
- PRICE T ROWE ASSOCIATES INC /MD/ added 495,985 shares (+210.6%) to their portfolio in Q3 2025, for an estimated $61,779,891
- PGGM INVESTMENTS removed 362,558 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $45,160,224
- SOROS FUND MANAGEMENT LLC removed 296,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $38,962,480
- MEREWETHER INVESTMENT MANAGEMENT, LP removed 295,712 shares (-98.3%) from their portfolio in Q3 2025, for an estimated $36,833,886
- NATIONAL BANK OF CANADA /FI/ removed 250,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $31,140,000
- SQUAREPOINT OPS LLC removed 244,770 shares (-73.8%) from their portfolio in Q3 2025, for an estimated $30,488,551
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ITRI Revenue
$ITRI had revenues of $581.6M in Q3 2025. This is a decrease of -5.5% from the same period in the prior year.
You can track ITRI financials on Quiver Quantitative's ITRI stock page.
$ITRI Analyst Ratings
Wall Street analysts have issued reports on $ITRI in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 10/16/2025
- Roth Capital issued a "Buy" rating on 07/22/2025
To track analyst ratings and price targets for $ITRI, check out Quiver Quantitative's $ITRI forecast page.
$ITRI Price Targets
Multiple analysts have issued price targets for $ITRI recently. We have seen 5 analysts offer price targets for $ITRI in the last 6 months, with a median target of $150.0.
Here are some recent targets:
- Ben Kallo from Baird set a target price of $118.0 on 10/31/2025
- Mark Strouse from JP Morgan set a target price of $155.0 on 10/16/2025
- Tommy Moll from Stephens & Co. set a target price of $130.0 on 10/07/2025
- Chip Moore from Roth Capital set a target price of $150.0 on 07/22/2025
- Joseph Osha from Guggenheim set a target price of $155.0 on 07/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
